Recruiting Lupus Studies in Syracuse
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
Systemic lupus erythematosus (SLE) is a chronic inflammatory disease which often has debilitating and potentially life-threatening consequences. The cause of SLE is unknown and current therapies lack ...
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
This is a Phase 1b/2, single-arm, open-label, multi-center, clinical study of AZD0120, a CD19/BCMA dual CAR T cell therapy, to evaluate the safety, tolerability, and efficacy in adult participants wit...
About Lupus Clinical Trials in Syracuse
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect the joints, skin, kidneys, brain, and other organs. It is more common in women and often involves periods of flares and remission. Treatment includes antimalarials, immunosuppressants, and biologics.
There are currently 2 lupus clinical trials recruiting participants in Syracuse, NY. These studies are seeking a combined 440 participants. Research is being sponsored by State University of New York - Upstate Medical University, AstraZeneca. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lupus Clinical Trials in Syracuse — FAQ
Are there lupus clinical trials in Syracuse?
Yes, there are 2 lupus clinical trials currently recruiting in Syracuse, NY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Syracuse?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Syracuse research site will contact you about next steps.
Are clinical trials in Syracuse free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Syracuse studies also compensate for your time and travel.
What lupus treatments are being tested?
The 2 active trials in Syracuse are testing new therapies including novel drugs, biologics, and treatment approaches for lupus.
Data updated March 2, 2026 from ClinicalTrials.gov